5,663 Contracts at Rs 1,100 Strike Price

Aurobindo Pharma Ltd., a prominent player in the Pharmaceuticals & Biotechnology sector, has emerged as one of the most active stocks today. The company’s underlying stock, AUROPHARMA, has seen significant trading activity, particularly in call options expiring on October 28, 2025. A total of 5,663 contracts were traded at a strike price of Rs 1,100, resulting in a turnover of approximately Rs 1,146.50 lakhs. The open interest stands at 1,655 contracts, indicating ongoing interest in this option.
In terms of performance, Aurobindo Pharma has outperformed its sector by 2.12%, marking a notable trend reversal after two consecutive days of decline. The stock opened with a gain of 2.45% and reached an intraday high of Rs 1,116, reflecting a 4.22% increase. Currently, the stock is trading above its 5-day, 20-day, and 50-day moving averages, although it remains below the 100-day and 200-day moving averages.

Despite a decrease in investor participation, with delivery volume dropping by 53.73% compared to the 5-day average, the stock maintains sufficient liquidity for trades up to Rs 1.75 crore, based on 2% of the 5-day average traded value. Aurobindo Pharma’s market capitalization is approximately Rs 62,687 crore, positioning it firmly within the mid-cap category. Overall, today’s activity highlights the stock’s resilience and ongoing market engagement.